Investigation of gastrointestinal tumor symptoms and risk factors in eighty patients with Parkinson’s disease

Table 4 Comparison of laboratory indicators of the two groups, mean ± SD

Characteristic	PD with gastrointestinal tumours (n = 16)	The PD was not accompanied by gastrointestinal tumors (n = 64)	t/χ2	P value
CEA (ng/mL)	7.33 ± 0.48	4.34 ± 0.33	29.414	< 0.001
CA19-9 (U/mL)	39.86 ± 2.08	28.01 ± 2.34	18.495	< 0.001
CA72-4 (U/mL)	8.31 ± 1.15	5.12 ± 0.44	17.809	< 0.001
TG (mmol/L)	0.98 ± 0.13	1.04 ± 0.24	0.962	0.339
TC (mmol/L)	4.31 ± 0.29	4.33 ± 0.19	0.336	0.738
HDL-C (mmol/L)	1.49 ± 0.16	1.45 ± 0.11	1.180	0.241
LDL-C (mmol/L)	2.38 ± 0.23	2.44 ± 0.13	1.391	0.168
ESR (mmol/L)	12.26 ± 1.34	12.34 ± 1.22	0.230	0.819

PD: Parkinson’s disease; CEA: Carcinoembryonic antigen; CA19-9: Carbohydrate antigen 19-9; CA72-4: Carbohydrate antigen 72-4; TG: Triglyceride; TC: Total cholesterol; HDL-C: High-density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol; ESR: Erythrocyte sedimentation rate.